Ultra-sensitive detection of protein biomarkers for diagnosis of Alzheimer's disease

Chemical Science
Hei-Nga ChanHung-Wing Li

Abstract

Beta amyloid peptide, tau, and phosphorylated tau are well recognized as promising biomarkers for the diagnosis of Alzheimer's disease (AD). In this work, we developed a direct, versatile, and ultrasensitive multiplex assay for the quantification of trace amounts of these protein biomarkers for AD in different types of biological fluids including cerebrospinal fluid, serum, saliva, and urine. The detection assay is based on the immunoreaction between the target proteins and their corresponding pair of antibodies followed by fluorescence labelling with a newly developed indolium-based turn-on fluorophore, namely SIM. SIM was tailor-made as a reporter to provide a high signal-to-noise ratio for the detection assay. An exceptionally low limit of detection down to the femto-molar level was achieved in this assay with minute consumption of the sample. This versatile detection assay is capable of reliably quantifying not only the target proteins simultaneously from a CSF sample in an hour but also trace amounts of protein biomarkers in saliva and urine. This assay has a high potential to serve as a practical tool for the diagnosis of AD.

References

Jun 13, 2003·Journal of Geriatric Psychiatry and Neurology·Linda M ErcoliGary W Small
Nov 11, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Niels AndreasenKaj Blennow
Jul 23, 2009·JAMA : the Journal of the American Medical Association·Niklas MattssonKaj Blennow
Jul 23, 2009·JAMA : the Journal of the American Medical Association·Ronald C Petersen, John Q Trojanowski
Aug 16, 2011·Journal of Alzheimer's Disease : JAD·Min ShiJing Zhang
May 11, 2012·Journal of Alzheimer's Disease : JAD·Li-San WangChristopher M Clark
Apr 30, 2013·Biosensors & Bioelectronics·Paola GagniMarcella Chiari
Oct 12, 2013·PloS One·Jere E MeredithCharles F Albright
Oct 26, 2013·Journal of Alzheimer's Disease : JAD·Takehiro KikoTeruo Miyazawa
May 6, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Kaj BlennowHarald Hampel
Aug 20, 2014·Electrophoresis·Raúl González-DomínguezJosé Luis Gómez-Ariza
Aug 21, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Silvia ContiMirco Vanelli Coralli
Nov 13, 2015·Analytical and Bioanalytical Chemistry·Pasquale PalladinoGiuseppe Spoto
Feb 7, 2016·Biosensors & Bioelectronics·Ajeet KaushikMadhavan Nair
Aug 30, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·UNKNOWN Alzheimer's Association

❮ Previous
Next ❯

Citations

Oct 30, 2019·Critical Reviews in Clinical Laboratory Sciences·Bhavana VeerabhadrappaSylvain Lehmann

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
fluorescence imaging

Software Mentioned

Simoa
Erenna

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.